Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

WX

(WX)

から:
次の項目別のソート:
 Showing the most relevant articles for your search:NYSE:WX
日付受信時刻ニュースソース見出しコード企業名
2019/03/0501 : 00Business WireIMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against WuXi PharmaTech (Caym...NYSE:WX
2019/03/0208 : 32Business WireIMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against WuXi PharmaTech (Cayman)...NYSE:WX
2017/09/0106 : 27Edgar (US Regulatory)Confidential Treatment Order (ct Order)NYSE:WX
2017/05/0200 : 29Edgar (US Regulatory)Confidential Treatment Order (ct Order)NYSE:WX
2016/09/2221 : 00PR Newswire (US)WuXi Biologics Completes Construction of Asia's Largest Perfusion Biologics Manufacturing Facility Using Disposable Bioreacto...NYSE:WX
2016/05/2500 : 36Edgar (US Regulatory)Confidential Treatment Order (ct Order)NYSE:WX
2016/05/2500 : 35Edgar (US Regulatory)Confidential Treatment Order (ct Order)NYSE:WX
2016/04/2717 : 18PR Newswire (US)LabNetwork Forges eCommerce Alliances with Leading Chemical ProvidersNYSE:WX
2016/02/1100 : 56Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:WX
2016/01/1200 : 37Edgar (US Regulatory)Schedule 13g
(sc 13g/a)
NYSE:WX
2015/12/1616 : 40PR Newswire (US)WuXi and AstraZeneca Form Strategic Alliance to Expedite Development of AstraZeneca's Innovative Biologics Portfolio in ChinaNYSE:WX
2015/12/1408 : 00PR Newswire (US)WuXi PharmaTech Presents 2015 Life Science and Chemistry AwardsNYSE:WX
2015/12/1204 : 10Edgar (US Regulatory)(25-NSE)NYSE:WX
2015/12/1107 : 14Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NYSE:WX
2015/12/1107 : 09Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NYSE:WX
2015/12/1107 : 02Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:WX
2015/12/1106 : 49Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NYSE:WX
2015/12/1106 : 45PR Newswire (US)WuXi PharmaTech (Cayman) Inc. Announces Completion of Going Private TransactionNYSE:WX
2015/12/1103 : 47Edgar (US Regulatory)Schedule 13g
(sc 13g/a)
NYSE:WX
2015/12/0809 : 00GlobeNewswire Inc.WuXi PharmaTech and PRA Health Sciences Restructure Relationship in ChinaNYSE:WX
2015/12/0722 : 00PR Newswire (US)Dr. Ge Li Receives Executive of the Year Award from SCRIPNYSE:WX
2015/12/0123 : 50Dow Jones NewsChina's Qihoo 360 Moving Closer to $9 Billion BuyoutNYSE:WX
2015/11/2520 : 19Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:WX
2015/11/2512 : 00PR Newswire (US)WuXi PharmaTech Announces Shareholders' Approval of Merger AgreementNYSE:WX
2015/11/2023 : 31Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NYSE:WX
2015/11/1220 : 23Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:WX
2015/11/1218 : 37PR Newswire (US)Genomics England Contracts with WuXi NextCODE as Clinical Interpretation Partner in both Rare Disease and CancerNYSE:WX
2015/11/1218 : 15PR Newswire (US)Genomics England Contracts with WuXi NextCODE as Clinical Interpretation Partner in both Rare Disease and CancerNYSE:WX
2015/11/1202 : 01PR Newswire (US)ISS and Glass Lewis Recommend that WuXi PharmaTech Shareholders Vote "FOR" the Proposed Going-Private TransactionNYSE:WX
2015/11/1106 : 30PR Newswire (US)WuXi PharmaTech and Lilly Announce Strategic Collaboration to Develop Novel Therapeutic in ChinaNYSE:WX
 Showing the most relevant articles for your search:NYSE:WX